{
    "clinical_study": {
        "@rank": "43454", 
        "brief_summary": {
            "textblock": "The evaluation will determine professional clinical accuracy comparing the OneTouch\u00ae\n      Verio\u2122Pro+ blood glucose results with the YSI 2300 analyzer.  \"Professional Clinical\n      Accuracy\" is defined as accuracy of the system when used by a trained healthcare\n      professional."
        }, 
        "brief_title": "OneTouch\u00ae Verio\u2122Pro+ Blood Glucose Monitoring System Clinical Accuracy Study in China", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Blood Glucose Measurement", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is at least 18 years of age.\n\n          -  Subject has been diagnosed with diabetes mellitus (type 1 or type 2 diabetes)\n\n          -  Subject agrees to sign two (2) copies each of the Subject Informed Consent Form and\n             to follow the procedures of the study.\n\n          -  Subject agrees to allow the HCP to perform finger stick for blood glucose test by the\n             meter and the YSI instrument. Up to one retry of finger stick will be needed in the\n             event of insufficient blood collected or test failure.\n\n          -  Subject agrees to allow the HCP to perform venous puncture for blood glucose test by\n             the meter and the YSI instrument, and for haematocrit (HCT) test. Up to one retry of\n             venous puncture will be needed in the event of insufficient blood collected or test\n             failure.\n\n          -  Subject agrees to provide demographic and medical history information and give access\n             to medical records where appropriate.\n\n        Exclusion Criteria:\n\n          -  Subject is currently working for, has previously worked for, or has an immediate\n             family member working for a company manufacturing and/or marketing blood glucose\n             monitoring products.\n\n          -  Subject has already participated in this study.\n\n          -  Subject is known pregnant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The study population will consist of at least 240 diabetic subjects (type 1 or type 2)\n        study-wide at two clinical sites."
            }
        }, 
        "enrollment": {
            "#text": "301", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01795625", 
            "org_study_id": "LFS-201201"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 18, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China"
                    }, 
                    "name": "Shanghai First People's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China"
                    }, 
                    "name": "Shanghai Jiaotong University, medical school affiliated Third People's Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Multi-centre, Open Clinical Evaluation to Determine Professional Clinical Accuracy Comparing the OneTouch\u00ae Verio\u2122Pro+ Blood Glucose Results With the YSI 2300 Analyzer.", 
        "overall_official": [
            {
                "affiliation": "Shanghai First People's Hospital", 
                "last_name": "Yongde Peng, Professor", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Shanghai Jiaotong University, medical school affiliated Third People's Hospital", 
                "last_name": "Fengling Chen, Professor", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "\u2022 Obtain professional clinical accuracy data for the OneTouch\u00ae Verio\u2122Pro+ blood glucose monitoring meter in comparison with a standard laboratory reference (YSI 2300 glucose analyzer) using a capillary blood sample and a venous sample", 
            "safety_issue": "No", 
            "time_frame": "August 20,2012~October 14,2012"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01795625"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Johnson & Johnson Medical, China", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Johnson & Johnson Medical, China", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}